Two-year overall survival rate in patients with steroid-resistant acute GvHD was 60% MELBOURNE, Australia, May 23, 2024 /PRNewswire/ — Cynata…
SYDNEY, May 22, 2024 /PRNewswire/ — Sungrow, a global leading PV inverter and energy storage system provider, has forged a…
The Kim Kardashian-loved brand is back again. MELBOURNE, Australia, May 22, 2024 /PRNewswire/ — Ten years ago, Memobottle revolutionised the way…
MELBOURNE, Australia , May 22, 2024 /PRNewswire/ – AI venture studio InnovateGPT Group has invested A$5.1 million in a new generative AI company, SpatialGPT,…
LOS ANGELES, May 22, 2024 /PRNewswire/ – Saviynt, a leading provider of cloud-native identity and governance platform solutions, today announced the…
SYDNEY, May 22, 2024 /PRNewswire/ — Today, Booking.com releases new research, with insights gathered from more than 31,000 travellers including…
WASHINGTON, May 21, 2024 /PRNewswire/ – Today, American Global Strategies LLC announced that former Australian Director of National Intelligence Nick Warner and…
SYDNEY, May 21, 2024 /PRNewswire/ – Proto Axiom, Australia’s first true biotech incubator, is thrilled to announce the launch of The…
ADELAIDE, Australia, May 21, 2024 /PRNewswire/ — Amp Energy ("Amp" or the "Company") announced today it has finalised all required…
CUPID is a Phase I safety and dosimetry study of TLX592, Telix’s investigational antibody-based targeted alpha therapy for prostate cancer….
